| III-62 Alicja Puszkiel Nivolumab de-escalation in patients with complete response: model-based simulations of alternative dosing regimens and noninferiority clinical trials Thursday 10:15-11:45 |
| III-62 Alicja Puszkiel Nivolumab de-escalation in patients with complete response: model-based simulations of alternative dosing regimens and noninferiority clinical trials Thursday 10:15-11:45 |